Chemoinformaics analysis of 5,8,11,14- Eicosatetraenoic acid
Molecular Weight | 318.501 | nRot | 14 |
Heavy Atom Molecular Weight | 284.229 | nRig | 5 |
Exact Molecular Weight | 318.256 | nRing | 0 |
Solubility: LogS | -6.316 | nHRing | 0 |
Solubility: LogP | 6.766 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 59.345 |
nHD | 0 | BPOL | 36.713 |
QED | 0.213 |
Synth | 2.772 |
Natural Product Likeliness | 0.92 |
NR-PPAR-gamma | 0.664 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.012 |
HIA | 0.007 |
CACO-2 | -4.493 |
MDCK | 0.0000274 |
BBB | 0.349 |
PPB | 0.940892 |
VDSS | 1.734 |
FU | 0.0270534 |
CYP1A2-inh | 0.972 |
CYP1A2-sub | 0.143 |
CYP2c19-inh | 0.664 |
CYP2c19-sub | 0.061 |
CYP2c9-inh | 0.884 |
CYP2c9-sub | 0.934 |
CYP2d6-inh | 0.175 |
CYP2d6-sub | 0.164 |
CYP3a4-inh | 0.763 |
CYP3a4-sub | 0.07 |
CL | 10.344 |
T12 | 0.394 |
hERG | 0.007 |
Ames | 0.382 |
ROA | 0.002 |
SkinSen | 0.985 |
Carcinogencity | 0.473 |
EI | 0.94 |
Respiratory | 0.806 |
NR-Aromatase | 0.399 |
Antiviral | No |
Prediction | 0.574194 |